Medtronic posts revenue, earnings growth and projects strong fiscal year guidance

Tim Casey | | Cardiovascular Business | Economics

Buoyed by its acquisition of Covidien, Medtronic’s revenue increased 6 percent in the fourth quarter of fiscal year 2016 and increased 7 percent for the fiscal year on a comparable, constant currency basis, the company announced on May 31.

Medtronic’s fiscal year 2016 ended on April 29. It was the first full year since Medtronic acquired Covidien in January 2015 for $50 billion.

Medtronic’s revenue was $7.567 billion for the fourth quarter and $28.833 billion for the year, while its diluted earnings per share increased slightly to $0.78 and $2.48, respectively.

The company earnings and revenue beat Wall Street analysts’ expectations. Medtronic’s shares were down approximately 1.65 percent to $80.35 per share as of 10:45 a.m. Eastern Time on May 31, less than three hours after the company released its results.

In the cardiac and vascular group, fourth quarter revenue increased 8 percent to $2.376 billion, including a 9 percent increase in the cardiac rhythm and heart failure division, a 7 percent increase in the coronary and structural heart division and an 8 percent increase in the aortic and peripheral vascular division.

During the quarter, Medtronic launched the Amplia MRI Quad CRT-D SureScan and the Compia MRI Quad CRT-D SureScan systems, the first MRI conditional cardiac resynchronization therapy defibrillators to treat patients with heart failure and reduce the risk of sudden cardiac arrest.

The company also had a 6 percent revenue growth in its minimally invasive therapies group, a 3 percent revenue increase in its restorative therapies group and a 10 percent revenue increase in its diabetes group.

For fiscal year 2017, Medtronic expects revenue growth of 5 percent to 6 percent and diluted earnings per share growth of 12 percent to 16 percent.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Cardiologist demand is on the rise—can hospitals keep up?
Cardiologist receives 35 months in prison for health insurance fraud
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."